Attenuating mitochondrial ROS by expressing mitochondrially targeted catalase reduced atrial dilatation and fibrosis and spontaneous AF in the transgenic mice expressing mutant NaV1.5 channels. The gene discussed is CAT; the disease is atrial fibrillation.